Infleqtion, Inc. (INFQ) - Q1 2026 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2026. Infleqtion, Inc. is a quantum technology company developing full-stack platforms including quantum sensing, computing, and software. The quarter was defined by the consummation of a business combination (SPAC merger) with Churchill Capital Corp X on February 13, 2026. Following the merger, the company is now a publicly traded entity on the NYSE under the symbol "INFQ" and is classified as an Emerging Growth Company.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Revenue | $9.46 million | $8.30 million |
| Gross Profit | $1.99 million | $3.38 million |
| Net Loss | $(30.26) million | $(5.99) million |
| Operating Cash Flow | $(19.16) million | $(6.97) million |
| Cash & Equivalents (End of Period) | $84.67 million | $11.69 million |
| Available-for-Sale Securities | $483.98 million | $51.48 million |
| Total Assets | $612.61 million | $115.31 million |
| Accumulated Deficit | $(261.35) million | $(231.09) million |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 14% to $9.46 million, driven by a 232% increase in service revenue ($6.31 million) primarily due to activity on the NASA Quantum Gravity Gradiometer (QGG) contract. This offset a 51% decline in product revenue.
- Expense Surge: Selling, General, and Administrative (SG&A) expenses skyrocketed 355% to $26.32 million. This was primarily due to $11.5 million in non-recurring transaction costs associated with the Business Combination and increased stock-based compensation.
- Liquidity Transformation: Cash and cash equivalents increased from $11.7 million to $84.7 million, and available-for-sale securities grew from $51.5 million to $484.0 million. This reflects net proceeds of approximately $528.2 million from the SPAC merger and PIPE investment.
- Capital Structure: All convertible redeemable preferred stock was converted to common stock upon the merger closing. There are now 216.5 million shares of common stock outstanding.
Guidance, Outlook, and Risks
- Outlook: Management believes current capital resources are sufficient to meet working capital and capital expenditure requirements for at least 12 months. The company expects to continue incurring operating losses as it invests in R&D and commercialization.
- Recent Contracts: Secured new awards including a $2.0 million DARPA contract (HARQ program), a $1.0 million U.S. Navy contract (QuIRC software), and a $5.3 million cost-sharing agreement with ARPA-E (ENCODE program).
- Strategic Partnerships: Announced integrations with NVIDIA (Sqale quantum computer and NVQLink), Safran (precision timing), and Voyager Technologies (space quantum tech).
- Material Weaknesses: The company disclosed that disclosure controls and procedures were not effective as of March 31, 2026, due to material weaknesses in internal controls over financial reporting. These include insufficient accounting personnel, lack of segregation of duties, and ineffective monitoring controls over the UK subsidiary. Remediation is expected to extend into 2027.
- Risks: Significant reliance on government contracts (85% of revenue), immaturity of quantum technology, and the need for substantial additional capital to achieve profitability.
Investor Verification Checklist
- Remediation Timeline: Verify the progress of remediation activities for the identified material weaknesses in internal controls, specifically regarding the UK subsidiary and equity record-keeping.
- Government Contract Renewals: Monitor the status of expiring government contracts (notably U.K. contracts) and the success of follow-on awards to sustain the 85% government revenue mix.
- Runway Analysis: Assess the burn rate against the $568 million+ in liquid assets (cash + securities) to confirm the 12-month liquidity runway claim given the high operating loss trajectory.
- Transaction Cost Impact: Confirm that the $11.5 million in expensed transaction costs are truly non-recurring and will not impact future quarters.
- Stock-Based Compensation: Review the $45.2 million in unrecognized stock-based compensation expense and its impact on future earnings.